June 14, 2021

On June 14, 2021, Paratek Pharmaceuticals, Inc. announced the appointment of Catholic Law alumna Minnie Baylor-Henry ’90 to the company’s Board of Directors.

Canadian Insider
Date: June 14, 2021
Paratek Appoints Minnie Baylor-Henry to Company’s Board of Directors

Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use, today announced the appointment of Minnie Baylor-Henry, J.D., a recognized leader in the area of food and drug laws and regulations, to the company’s Board of Directors.

“We’re delighted to welcome Minnie to Paratek’s Board of Directors,” said Michael Bigham, Chairman of the Board for Paratek. “She brings extensive expertise and unique perspectives from her work with top global businesses, government agencies and leading non-profit organizations that will be invaluable as we continue to pursue life cycle initiatives for NUZYRA and continue our commitment to supporting the fight against antimicrobial resistance.”

To read more about Minnie Baylor-Henry’s appointment, click here.